ASCO Genitourinary Cancer Renalv2.indd


New Combination to Treat RCC Provides “CLEAR” Results in Phase 3 Trial

Hope for Improving Surgical Outcomes in RCC

UPDATE ON KEYNOTE-426: Combo Offers Durable Survival Benefit in Patients with Advanced Disease

New Data Stand Out for Health-Related Quality of Life in mRCC

Follow-Up on Phase III JAVELIN Renal Trial: A+Ax vs S

MET Kinase Inhibitors vs Sunitinib For pRCC